Company: PHAT
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057326
Chunk: 41

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 41
---
 in the Phathom Stock Fund in our 401(k) plan, 168,333 shares of common stock issuable to Dr. Nabulsi upon the exercise of options that are exercisable within 60 days following April 7, 2025, and 785,700 shares of common stock held by the Azmi A. Nabulsi Living Trust. Azmi Nabulsi is a trustee of the Azmi A. Nabulsi Living Trust and in such capacity has the sole power to vote and dispose of such shares. Fractional shares rounded to nearest whole share.

Consists of 73,500 shares held directly by Dr. Parikh acquired through direct purchases and stock option exercises, 45,000 shares of common stock issuable to Dr. Parikh upon the exercise of options that are exercisable within 60 days following April 7, 2025, and 19,500 shares of common stock issuable to Dr. Parikh upon the vesting of restricted stock units that have vested or are scheduled to vest within 60 days following April 7, 2025.

Consists of 410 shares of common stock held in the Phathom Stock Fund in our 401(k) plan, 60,000 shares of common stock issuable to Mr. Socks upon the exercise of options that are exercisable within 60 days following April 7, 2025, and 19,500 shares of common stock issuable to Mr. Socks upon the vesting of restricted stock units that have vested or are scheduled to vest within 60 days following April 7, 2025, and 1,211,346 shares of common stock held by the David A. Socks 2013 Revocable Trust. David Socks is a trustee of the David A. Socks 2013 Revocable Trust and in such capacity has the sole power to vote and dispose of such shares. Fractional shares rounded to nearest whole share.

Consists of 80,000 shares of common stock issuable to Mr. Stenhouse upon the exercise of options that are exercisable within 60 days following April 7, 2025, and 19,500 shares of common stock issuable to Mr. Stenhouse upon the vesting of restricted stock units that have vested or are scheduled to vest within 60 days following April 7, 2025.

Includes of 59,166 shares of common stock issuable to Dr. Topper upon exercise of options that are